|
Age in years
|
86.0; 85.0 (7.5)
|
87.0; 84.8 (7.2)
|
87.5; 88.0 (5.6)
|
|
Baseline QoLd (EQ-5D score)
|
0.33; 0.38 (0.33)
|
0.45; 0.46 (0.26)
|
0.38; 0.41 (0.33)
|
|
Baseline functional status (Barthel Index)
|
57.0; 55.5 (23.3)
|
61.0; 59.8 (19.2)
|
60.5; 58.4 (20.9)
|
|
Baseline cognitive function (SMMSEe score)*
|
25.0; 23.3 (5.7)
|
19.5; 19.2 (5.8)
|
23.5; 23.4 (4.3)
|
|
Baseline depressive symptoms (GDS-15f score)
|
6.0; 5.8 (2.7)
|
5.0; 5.6 (2.9)
|
4.5; 6.0 (3.6)
|
|
Body mass index (BMI)g
|
22.2; 23.6 (6.5)
|
24.0; 24.9 (5.3)
|
22.9; 23.9 (5.0)
|
|
Gender [n,(%) male]
|
15 (43)
|
12 (57)
|
5 (25)
|
|
n (%) who had a QoLh gain over 12 months
|
13 (41)
|
7 (41)
|
8 (44)
|
|
n (%) who had died at the end of 12 months
|
10 (29)
|
6 (29)
|
2 (10)
|
|
Place of death [n (%) in each column]
| | | |
|
Hospital
|
6 (60)
|
3 (50)
|
1 (50)
|
|
Residential Care/Respite
|
4 (40)
|
3 (50)
|
1 (50)
|
|
Home/Independent living unit
|
0
|
0
|
0
|
|
When AD was completedi
| | | |
|
Before admission to TCj
|
0
|
17 (81)
|
5 (25)
|
|
During admission to TCj
|
35 (100)
|
2 (10)
|
15 (70)
|
|
Trial Arm
| | | |
|
Intervention*
|
30 (86)
|
14 (67)
|
9 (45)
|
|
Usual care*
|
5 (14)
|
7 (33)
|
11 (55)
|
